HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease
暂无分享,去创建一个
Alberto Lleó | Marta Blázquez | V. Álvarez | J. Clarimón | A. Lleó | I. Illán-Gala | M. Menéndez-González | M. Blázquez | Renée Ribacoba | Manuel Menéndez-González | Jordi Clarimón | Ignacio Illán-Gala | C. Martínez | Carmen Martínez | Irene Rosas-Allende | Esther Suárez San Martín | Ciara García-Fernández | Oriol Dols-Icardo | Germán Morís | Victoria Álvarez | G. Morís | R. Ribacoba | Irene Rosas-Allende | O. Dols-Icardo | Ciara García-Fernández
[1] L. Agostinho,et al. REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review. , 2017, Genetics and molecular research : GMR.
[2] Carsten Saft,et al. Huntington's disease as caused by 34 CAG repeats , 2008, Movement disorders : official journal of the Movement Disorder Society.
[3] I. Shelef,et al. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy? , 2009, Journal of the Neurological Sciences.
[4] M. Bee,et al. ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis , 2017, Neurobiology of Aging.
[5] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[6] E. Lyon,et al. Triplet repeat primed PCR simplifies testing for Huntington disease. , 2013, The Journal of molecular diagnostics : JMD.
[7] Ashley R. Jones,et al. ATXN2 trinucleotide repeat length correlates with risk of ALS , 2017, Neurobiology of Aging.
[8] Thomas J Hudson,et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. , 2009, American journal of human genetics.
[9] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[10] S. Martínez-Horta,et al. Clinical manifestations of intermediate allele carriers in Huntington disease , 2016, Neurology.
[11] Suman Jayadev,et al. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects. , 2014, Journal of Huntington's disease.
[12] Robert A. Schoevers,et al. Huntingtin gene repeat size variations affect risk of lifetime depression , 2017, Translational Psychiatry.
[13] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[14] Suzanne Powell,et al. Autopsy‐proven Huntington's disease with 29 trinucleotide repeats , 2007, Movement disorders : official journal of the Movement Disorder Society.
[15] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[16] Yi-Min Sun,et al. Huntington’s Disease: Relationship Between Phenotype and Genotype , 2015, Molecular Neurobiology.
[17] Jane S. Paulsen. Cognitive Impairment in Huntington Disease: Diagnosis and Treatment , 2011, Current neurology and neuroscience reports.
[18] Jessica K. Lee,et al. Effect of Trinucleotide Repeats in the Huntington's Gene on Intelligence , 2018, EBioMedicine.
[19] S. Warby,et al. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles , 2006, Clinical genetics.
[20] J. Jankovic,et al. Exploring the Correlates of Intermediate CAG Repeats in Huntington Disease , 2011, Postgraduate medicine.
[21] T. Gillis,et al. Prevalence of Huntington's disease gene CAG repeat alleles in sporadic amyotrophic lateral sclerosis patients , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[22] F. Cardoso. Nonmotor Symptoms in Huntington Disease. , 2017, International review of neurobiology.
[23] J. Jankovic,et al. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS , 2013, Neurology.
[24] R. Roos,et al. Late-onset Huntington’s disease with intermediate CAG-repeats: true or false? , 2009 .